BackAmbrx Biopharma Overview

Ambrx Biopharma Inventory

Track Ambrx Biopharma's inventory ($5.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$5.39M
539399900.00% YoYΔ $5.39M vs prior year quarter

Peer trimmed avg / median

Loading

Ambrx Biopharma Inventory History

Loading

Ambrx Biopharma vs. peers: Inventory Comparison

Loading

Ambrx Biopharma Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ambrx Biopharma (AMAM) FAQ

As of the most recent data (September 2023), AMAM shows a inventory of $5.4M. That compares with $1 in the prior-year period — up 539399900.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMAM's inventory is now $5.4M (was $1) — a 539399900.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ambrx Biopharma is outperforming or lagging.

Tracking AMAM's inventory over time shows whether Ambrx Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $5.4M That compares with $1 in the prior-year period — up 539399900.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Ambrx Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $5.4M) with ownership activity and broader fundamentals.

Ambrx Biopharma's inventory is $5.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.